Brad L. Tade - 19 Feb 2026 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
CFO and Treasurer
Signature
/s/ Brad L. Tade, by Michael A. Goldstein as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
19 Feb 2026
Net transactions value
-$105,737
Form type
4
Filing time
23 Feb 2026, 21:00:18 UTC
Previous filing
28 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tade Brad L. CFO and Treasurer C/O ADMA BIOLOGICS, INC., 5800 PARK OF COMMERCE BLVD. NW, BOCA RATON /s/ Brad L. Tade, by Michael A. Goldstein as Attorney-in-fact 23 Feb 2026 0002030561

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Tax liability $105,737 -6,479 -2.7% $16.32 232,940 19 Feb 2026 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
F2 Includes, as of the transaction date, (i) 46,671 unvested RSUs out of 62,227 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 54,300 unvested RSUs granted on July 24, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
F3 (continued from footnote 2) (iii) 37,500 unvested RSUs granted by the Company on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
F4 (continued from footnote 3) (iv) 50,000 unvested RSUs, granted by the Company on June 26, 2023, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (v) 44,469 shares acquired in open market purchases and pursuant to the vesting of RSUs after the withholding of shares to cover applicable taxes.